Literature DB >> 9346233

KSHV and Kaposi's sarcoma: the end of the beginning?

D Ganem1.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9346233     DOI： 10.1016/s0092-8674(00)80398-0

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


× No keyword cloud information.
  82 in total

1.  Identification of human herpesvirus 8-specific cytotoxic T-cell responses.

Authors:  M Osman; T Kubo; J Gill; F Neipel; M Becker; G Smith; R Weiss; B Gazzard; C Boshoff; F Gotch
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus.

Authors:  R Sadler; L Wu; B Forghani; R Renne; W Zhong; B Herndier; D Ganem
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

3.  Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins.

Authors:  S Ishido; C Wang; B S Lee; G B Cohen; J U Jung
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

4.  Antiapoptotic herpesvirus Bcl-2 homologs escape caspase-mediated conversion to proapoptotic proteins.

Authors:  D S Bellows; B N Chau; P Lee; Y Lazebnik; W H Burns; J M Hardwick
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

5.  Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirus.

Authors:  A J Aguirre; E S Robertson
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  Lytic replication of Kaposi's sarcoma-associated herpesvirus results in the formation of multiple capsid species: isolation and molecular characterization of A, B, and C capsids from a gammaherpesvirus.

Authors:  K Nealon; W W Newcomb; T R Pray; C S Craik; J C Brown; D H Kedes
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

7.  CAK-independent activation of CDK6 by a viral cyclin.

Authors:  P Kaldis; P M Ojala; L Tong; T P Mäkelä; M J Solomon
Journal:  Mol Biol Cell       Date:  2001-12       Impact factor: 4.138

8.  Immunoreceptor tyrosine-based activation motif-dependent signaling by Kaposi's sarcoma-associated herpesvirus K1 protein: effects on lytic viral replication.

Authors:  M Lagunoff; D M Lukac; D Ganem
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

9.  Human immunodeficiency virus replication in a primary effusion lymphoma cell line stimulates lytic-phase replication of Kaposi's sarcoma-associated herpesvirus.

Authors:  V Varthakavi; P J Browning; P Spearman
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

10.  The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells.

Authors:  Jianhong Hu; Alexander C Garber; Rolf Renne
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.